MedTwenty
Market Analysis

Cancer Genomics Outlook

Comprehensive genomic profiling, minimal residual disease and the competitive position of the vertically integrated providers.

Contents

  • Segment sizing and test volume
  • Provider competitive positions post-Tempus/Personalis
  • NHS Genomic Medicine Service contracting
  • Reimbursement and pricing benchmarks

Download the full report

This report is included with Professional and Enterprise membership, or available as a single purchase. Methodology and source basis are stated in the opening section.

Upgrade